Background To investigate the impact of high circulating AMH on the outcome of CC
ovulation induction in women with PCOS. Methods This prospective cohort observational …

Context: Elevated serum anti-Müllerian hormone (AMH) concentration in women with
polycystic ovarian syndrome (PCOS) is known to lower sensitivity of ovarian follicles to …

The present retrospective cohort study was conducted to investigate whether serum anti-
Müllerian hormone (AMH) levels, determined by either the Immunotech (IOT) or the second …

Purpose To assess whether anti-Müllerian hormone (AMH) can predict response to
ovulation induction (OI) with clomiphene citrate (CC), letrozole (LET), or follicle-stimulating …

Background Women with polycystic ovarian syndrome (PCOS) are known to have elevated
circulating Anti-Müllerian hormone (AMH), which has been found to desensitize ovarian …

Purpose: To investigate the ability of anti-Mullerian hormone (AMH) to predict the step up of
human menopausal gonadotropins (HMG) dose in women with polycystic ovarian syndrome …

Context: Anti-Müllerian hormone (AMH) reduces aromatase activity and sensitivity of follicles
to FSH stimulation. Therefore, elevated serum AMH may indicate a higher threshold for …

In the human ovary, expression of anti-Müllerian hormone (AMH) is detected primarily in
granulosa cells of preantral and small antral follicles. The aim of this study was to compare …

Objective To describe the serum anti-Müllerian hormone (AMH) concentrations in a large,
well-phenotyped cohort of women with polycystic ovary syndrome (PCOS) and evaluate …

Aim The present study was conducted to correlate serum AMH levels with Polycystic Ovarian
Syndrome (PCOS) and type of treatment protocol. Materials and Methods Serum AMH levels …